Middle East Healthcare Co.

39
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA141H01UKH9
SAR
34.40
-0.08 (-0.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
2,882.00
2,653.00
2,151.00
1,872.00
1,750.00
1,496.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
2,882.00
2,653.00
2,151.00
1,872.00
1,750.00
1,496.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,393.00
1,301.00
1,173.00
1,034.00
925.00
789.00
Operating Expenses
224.00
159.00
70.00
52.00
35.00
27.00
General and Administration Expenses
610.00
603.00
489.00
506.00
438.00
351.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
2,436.00
2,284.00
1,994.00
1,811.00
1,639.00
1,391.00
Operating Profit (PBDIT) excl Other Income
446.00
368.00
157.00
61.00
110.00
105.00
Other Income
42.00
13.00
8.00
10.00
5.00
17.00
Operating Profit (PBDIT)
704.00
571.00
297.00
212.00
243.00
220.00
Interest
224.00
159.00
70.00
52.00
35.00
27.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
216.00
189.00
145.00
141.00
127.00
98.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
310.00
190.00
81.00
19.00
80.00
95.00
Provision for Tax
26.00
170.00
9.00
7.00
5.00
5.00
Profit After Tax
282.00
17.00
75.00
17.00
81.00
97.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
3.06
0.19
0.82
0.19
0.89
1.06
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 8.66% vs 23.30% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 21.00% vs 134.37% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 40.69% vs 127.58% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 1,555.09% vs -77.34% in Dec 2023

Compare Profit and Loss Results of Middle East Healthcare Co.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
No of Months
12
12
Operating Income
2,882.00
0
2,882.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
2,882.00
0
2,882.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
1,393.00
0
1,393.00
0%
Operating Expenses
224.00
0
224.00
0%
General and Administration Expenses
610.00
0
610.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
2,436.00
0
2,436.00
0%
Operating Profit (PBDIT) excl Other Income
446.00
0.00
446.00
0%
Other Income
42.00
0
42.00
0%
Operating Profit (PBDIT)
704.00
0
704.00
0%
Interest
224.00
0
224.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
216.00
0
216.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
310.00
0
310.00
0%
Provision for Tax
26.00
0
26.00
0%
Profit After Tax
282.00
0
282.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.0639
0
3.06
0%
Profit And Loss - Net Sales
Net Sales 2,882.82 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 8.66% vs 23.30% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 446.08 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.00% vs 134.37% in Dec 2023

Profit And Loss - Interest
Interest 224.83 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.69% vs 127.58% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 282.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1,555.09% vs -77.34% in Dec 2023